Prescient, operating under the slogan "See further, go deeper", is a strategic consultancy specializing in bioscience. Established in 2007 and headquartered in the United Kingdom, the company provides integrated, competitive, and customer insight-driven strategies across the full drug lifecycle.
With a focus on biotechnology, healthcare, and pharmaceuticals, Prescient leverages its deep scientific and clinical insights to forge meaningful partnerships in pursuit of transformative innovation. By combining strategic rigor and scientific expertise, the company aims to unlock the full potential of healthcare advancements, ultimately benefiting global health outcomes.
Having become a portfolio company of Bridgepoint Development Capital in 2021 and Baird Capital since 2017, Prescient received its most recent investment during a Private Equity Round on 27 July 2017. These strategic partnerships underscore its commitment to advancing innovation within the industry.